https://thevitalrecord.ai/2026/06/17/ebola-bdbv-drc-808-confirmed-no-vaccine/ The Vital Record en 2026-06-17T00:00:00.000Z Ebola Case Count in DRC Climbs to 808 Confirmed as Absence of BDBV Vaccine Widens Response Gap https://thevitalrecord.ai/2026/06/17/the-bundibugyo-gap-ebola-playbook-doesnt-apply/ The Vital Record en 2026-06-17T00:00:00.000Z The Bundibugyo Gap: A Warning the World's Ebola Playbook Doesn't Apply Here https://thevitalrecord.ai/2026/06/17/fda-no-major-deficiencies-moderna-mrna-flu-vaccine-vrbpac/ The Vital Record en 2026-06-17T00:00:00.000Z FDA Staff Find No Major Deficiencies in Moderna's mRNA Flu Vaccine as Panel Vote Looms https://thevitalrecord.ai/2026/06/17/plasma-aging-clocks-60542-nature-medicine-2026/ The Vital Record en 2026-06-17T00:00:00.000Z A Single Cell Type Ages Faster in 1 in 5 People — and It Tracks Their Disease Risk https://thevitalrecord.ai/2026/06/17/fda-cleared-ai-sepsis-monitor-bayesian-health-trews/ The Vital Record en 2026-06-17T00:00:00.000Z FDA Cleared an AI Sepsis Monitor in April; Prospective Data Show an 18.7% Relative Mortality Reduction — With Conditions https://thevitalrecord.ai/2026/06/16/triple-drug-regimen-halves-progression-risk-in-hard-to-treat-myeloma/ The Vital Record en 2026-06-16T00:00:00.000Z Triple-Drug Regimen Halves Progression Risk in Hard-to-Treat Myeloma https://thevitalrecord.ai/2026/06/16/what-successor-2-tells-us-about-the-celmod-era-in-myeloma/ The Vital Record en 2026-06-16T00:00:00.000Z What SUCCESSOR-2 Tells Us About the CELMoD Era in Myeloma https://thevitalrecord.ai/2026/06/16/dpp-25-year-followup-lifestyle-cuts-multimorbidity-metformin-does-not/ The Vital Record en 2026-06-16T00:00:00.000Z At 25 Years, Lifestyle Cuts Multimorbidity Risk; Metformin Does Not https://thevitalrecord.ai/2026/06/16/ai-oct-grading-cuts-diabetic-macular-edema-false-referrals-45-points/ The Vital Record en 2026-06-16T00:00:00.000Z AI Grading Cuts False Referrals by 45 Points in Diabetic Macular Edema Screening https://thevitalrecord.ai/2026/06/16/abbvie-opens-pivotal-gene-therapy-trial-for-diabetic-retinopathy-naavi/ The Vital Record en 2026-06-16T00:00:00.000Z AbbVie Opens Pivotal Gene Therapy Trial for Diabetic Retinopathy https://thevitalrecord.ai/2026/06/16/nci-suspends-phase-3-cemiplimab-trial-resectable-skin-cancer/ The Vital Record en 2026-06-16T00:00:00.000Z NCI Suspends Phase 3 Cemiplimab Trial in Resectable Skin Cancer